Viking Therapeutics (VKTX) Q3 2024 Earnings

24JulConfirmed
Q3 2023
Q4 2023
Q1 2024
Q3 2024
-0.28
-0.25
-0.23
-0.2

Details

Expected EPS
-0.262638
Actual EPS
-0.2
Surprise EPS
0.06
Surprise Percent
+23.85%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.2 per share for Q3 2024.

0 Comments

Share your thoughts